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Abstract
Background: Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal
mechanism of aging. Here we tested this hypothesis in healthy individuals of different ages by examining unrepaired DNA
double-strand breaks (DSBs) in hematopoietic stem/progenitor cells matured in their physiological microenvironment.
Methodology/Principal Findings: To asses DNA damage accumulation and repair capacities, cH2AX-foci were examined
before and after exposure to ionizing irradiation. Analyzing CD34+ and CD342 stem/progenitor cells we observed an
increase of endogenous cH2AX-foci levels with advancing donor age, associated with an age-related decline in telomere
length. Using combined immunofluorescence and telomere-fluorescence in-situ hybridization we show that cH2AX-foci co-
localize consistently with other repair factors such as pATM, MDC1 and 53BP1, but not significantly with telomeres, strongly
supporting the telomere-independent origin for the majority of foci. The highest inter-individual variations for non-
telomeric DNA damage were observed in middle-aged donors, whereas the individual DSB repair capacity appears to
determine the extent of DNA damage accrual. However, analyzing different stem/progenitor subpopulations obtained from
healthy elderly (.70 years), we observed an only modest increase in DNA damage accrual, most pronounced in the
primitive CD34+CD382-enriched subfraction, but sustained DNA repair efficiencies, suggesting that healthy lifestyle may
slow down the natural aging process.
Conclusions/Significance: Based on these findings we conclude that age-related non-telomeric DNA damage accrual
accompanies physiological stem cell aging in humans. Moreover, aging may alter the functional capacity of human stem
cells to repair DSBs, thereby deteriorating an important genome protection mechanism leading to exceeding DNA damage
accumulation. However, the great inter-individual variations in middle-aged individuals suggest that additional cell-intrinsic
mechanisms and/or extrinsic factors contribute to the age-associated DNA damage accumulation.
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Introduction
Long-lived multicellular organisms depend on tissue replenish-
ment from small pools of tissue-specific stem cells that have the
ability to self-renew and to generate differentiated progeny. A
diminished capacity to maintain tissue homeostasis is a central
physiological characteristic of aging, and the depletion of stem cell
reserves and/or diminished stem cell functions have been
postulated to contribute to aging. Recent studies suggest that
accumulated DNA damage could be a principal mechanism
underlying age-dependent stem cell decline.
The most deleterious form of DNA damage are DNA double-
strand breaks (DSBs), which arise under physiological conditions
predominantly from oxidative damage [1], or are caused by
genotoxic insults such as ionizing radiation, and are repaired by
non-homologous end-joining (NHEJ) and homologous recombi-
nation. Endogenous as well as radiation-induced DSBs provoke a
DNA damage response characterized by the activation and
recruitment of ATM (Ataxia Telangiectasia mutated) leading to
the phosphorylation of Ser-139 of histone H2AX molecules
adjacent to break sites. This phosphorylated form of H2AX,
termed cH2AX, can be visualized by immunofluorescence
analysis and form discrete nuclear foci, which co-localize with
other repair factors such MDC1 (mediator of DNA damage
checkpoint protein 1) or 53BP1 (p53 binding protein 1) and reflect
sites of DSBs [2,3]. cH2AX-foci analysis is a highly sensitive
technique to detect DSBs, and this type of analysis has shown that
the kinetics of cH2AX-foci loss strongly correlate with the time
course of DSB repair [3–6].
Unrepaired DSBs labeled by the cH2AX-foci approach have
been shown to accumulate in aging fibroblasts in culture as well as
in normal tissues of aged animals [7–10]. Further experimental
data indicate that the accumulation of DNA damage may
contribute to the dysfunction of hematopoietic stem cells (HSCs)
[11]. To examine the consequences of DNA damage accrual on
stem cell biology, HSC reserves and functional capacities were
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17487quantified during aging of mice bearing mutations in several DNA
repair pathways including nucleotide excision repair (Xpd
TTD
mice) and NHEJ (Lig4
2/2 and Ku80
2/2 mice). Although
deficiencies in these pathways did only partly deplete stem cell
reserves with age, stem cell functional capacities were severely
affected under conditions of stress, leading to loss of reconstitution
and proliferative potential, diminished self-renewal, increased
apoptosis and, ultimately, functional exhaustion [12,13]. More-
over, recent studies analyzing kinetics of cH2AX-foci formation
and recruitment of DSB repair proteins to the break sites in young
and senescing fibroblasts indicate that the ability of human cells to
sense and repair DNA damages may decline with age [14].
Together, these findings suggest that the exhaustion of stem cell
function may result from the accumulation of DNA damage.
Another important aspect in this context is the telomere
dysfunction in response to critical telomere shortening, which
may induce DNA damage responses [15]. In primary human cells,
telomeres shorten with each round of cell division, primarily due to
the end-replication problem of DNA polymerase. To counteract
telomere loss, a specific enzyme telomerase is required to add
DNA sequence repeats (TTAGGG) to the 39end DNA strands.
Telomerase activity is important to remain the self-renewal of stem
cells. However, telomeres shorten in human HSCs during aging
suggesting that the level of telomerase activity is not sufficient to
maintain telomere length in aging stem cells [16]. When telomeres
reach critically short length, they cannot maintain proper structure
at chromosomal ends, which then become unprotected. Upon
telomere uncapping, the open chromosomal ends activate DNA
damage responses inducing a permanent cell cycle arrest, which is
referred as ‘‘replicative senescence’’ [17]. Thus it is conceivable
that human HSCs experience telomere shortening and the
induction of checkpoints in response to telomere dysfunction
could contribute to the decline in stem function during aging.
However, much of the evidence implicating DNA damage accrual
and telomere dysfunction as important mechanisms governing the
aging process has emerged through in-vitro studies of human
fibroblasts, or animal models with engineered mutations in diverse
DNA repair pathways. Thus, the question of whether or not DNA
damage accumulates in tissue stem cells of human individuals during
physiological aging remains at issue. HSCs are the best-characterized
stem cells in humans, functioning to ensure the lifelong production of
all the diverse cell types of the hematopoietic system. HSCs have
emerged as a model system for studying the effects of aging on stem
cell biology since they can be purified to near homogeneity based on
their unique pattern of surface markers [18]. The enrichment of
CD34+ cells is current practice in hematopoietic stem cell
transplantation and to date one of the most efficient cell separation
methods for autologous and allogenic bone marrow transplantations
[19]. However, these CD34+ cells are a heterogeneous mixture of
cells that can be further separated into the immature or pluripotent
CD382 cells and the more mature or committed CD38+ cells. It is
postulated that immature CD34+CD382 cells could be responsible
for long-term hematopoietic reconstitution, whereas more mature
CD34+CD38+ cells could be responsible for early engraftment after
bone-marrow transplantation [20].
Using the highly sensitive cH2AX-foci approach, we analyzed
spontaneous DSBs in human HSCs and their downstream
progeny of healthy individuals to evaluate endogenous DNA
damage accumulation in connection with telomere shortening
during physiological aging. Moreover, the formation and loss of
cH2AX-foci in different stem and progenitor populations exposed
to ionizing irradiation was analyzed to gain insights into age-
dependent changes in DSB repair capacity. The primary
objectives of this study were to evaluate whether DNA damage
accrual may be a pathophysiological mechanism of stem cell aging
in humans that may contribute to the diminished functional
capacity of aged stem cells to maintain tissue homeostasis.
Materials and Methods
Ethics statement
This study (‘‘Altersabha ¨ngige DNA Reparatur in ha ¨matopoe-
tischen Stammzellen’’ Kenn-Nr: 128/09) was approved by the
local ethics committee (‘‘Ethikkommission der A ¨rztekammer des
Saarlandes’’) and all participants gave written informed consent.
Healthy donors and cell separation
Bone marrow and growth-factor mobilized peripheral blood of
healthy volunteers (16–83 years; n=68) or umbilical cord blood
(n=34) were obtained according to the guidelines of the local ethics
committee. Mononuclear cells were separated by Ficoll gradient
centrifugation (Percoll, PAA, Germany). HSCs were purified by
CD34+ immunomagnetic beads (CD34 MicroBeadKit, Miltenyi,
Bergisch Gladbach, Germany), and purity generally exceeded 95%.
In asecond separationstep, the CD34+cellsubsetsweremagnetically
separated based on CD38 (CD34 MultiSort Kit, CD38 MicroBe-
adKit, Miltenyi, Bergisch Gladbach, Germany) to isolate the distinct
CD34+CD38+ and CD34+CD382 subpopulations.
Irradiation
Purified cell populations diluted in RPMI 1640 (Biochrom,
Berlin, Germany) were irradiated with 1 Gy or 2 Gy, respectively
(90 kV; 25 mA; dose-rate: 1.2 Gy/min; 2 mm aluminum filter).
At defined time-points (0.25 h; 0.5 h; 2 h; 4 h; 8 h; 24 h) after
irradiation samples were centrifuged and spotted onto cover slips.
Immunofluorescence analysis
Cells were fixed in methanol, permeabilized in acetone and
incubated with anti-cH2AX-antibody (Millipore, Billerica MA,
USA), anti-pATM (phosphoS1981) (Abcam, Cambridge MA,
USA), anti-MDC1 or anti-53BP1 (Bethyl, Montgomery TX, USA)
followed by Alexa-Fluor-488 or Alexa-Fluor-568 conjugated
secondary antibodies (Invitrogen, San Diego CA, USA). Finally,
samples were mounted by using vectashield mounting medium
with 49,6-diamidino-2-phenylindole (Vector Laboratories, Burlin-
game CA, USA). For quantitative analysis, foci were counted per
cell using Nikon E600 epifluorescence microscope with 606and
1006 magnification objective (Nikon, Tokyo, Japan). Under
blinded conditions, cell/foci counting were performed until at
least 40 cells and 40 foci were registered in every sample.
Telomere length analysis
Telomere length measurements were done by flow fluorescence
in-situ hybridization (FISH), as described previously [16,21,22]. In
brief, cells were incubated with FITC-labelled telomere-specific
(CCCTAA)3 peptide nucleic acid probe (Applied Biosystems,
Langen, Germany) and DNA was counterstained with LDS 751
(Exciton, Dayton OH, USA). Flow cytometric analysis was
performed on FACS Calibur flow cytometer (Becton Dickinson,
Heidelberg, Germany). Telomere length was expressed as mean
fluorescent signal intensity. It was converted into base pairs
according to a previously established standard curve [16].
Co-localization of cH2AX-foci with telomere-specific
signals
Telomere labeling was accomplished with a telomere-specific
peptide nucleic acid probe conjugated with FAM-fluorochrome
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manufacturer’s protocol. Subsequently, samples were stained for
cH2AX, as already described. For the different cell populations,
approximately 200 cH2AX-foci were examined for co-localization
with the telomere-specific signals using Nikon E600 epifluores-
cence microscope.
Statistics
Linear regression analyses and Spearman’s rank correlation
coefficients were calculated for pre-existing as well as residual
DSBs versus donor age and telomere length. To evaluate potential
differences in DSB accumulation and DSB repair capacity
between the diverse age-groups, statistical comparisons were
performed by Mann-Whitney-U test. The criterion for statistical
significance was p#0.05.
Results
cH2AX-focus formation is currently the most sensitive assay to
monitor DSB levels in individuals. In pilot experiments measuring
foci numbers produced by low-level radiation exposure we
intended to evaluate the dose range yielding linearity between
foci number and dose. Figure 1A shows that the induction of DSBs
is clearly dependent on the irradiation dose, with a linear
correlation even after very low doses. Moreover, these cH2AX-
foci consistently co-localize with other DNA repair factors such as
pATM, MDC1 and 53BP1 (Fig. 1B, 1C), confirming that this
marker can be used to analyze DSBs. In further experiments we
could show that endogenous foci numbers do not vary during
culture time, with stable foci counts over a period of more than
72 hours. Moreover, DNA flow cytometry analysis using propi-
dium iodide revealed that CD34+ and CD342 cells obtained from
umbilical cord blood and adult bone marrow show similar cell
cycle distributions with about 85% in G1/G0-, 5–9% in S- and 3–
7% in G2/M-phase (data not shown). Collectively, these findings
suggest that cH2AX-foci analysis represent a reliable and
exquisitely sensitive technique to monitor DSBs in human
haematopoietic stem and progenitor cells.
Subsequently, we analyzed the pre-existing DSBs in CD34+ and
CD342 cells derived from various stem cell sources (umbilical
cord blood, growth-factor mobilized peripheral blood, bone
marrow), by counting cH2AX-foci per cell. In figure 2 (upper
panels) the number of cH2AX-foci was plotted against the
chronological donor age, depicted separately for CD34+ and
CD342 cells. In CD34+ cells obtained from umbilical cord blood
(age-group 0) the number of cH2AX-foci was generally fairly low
with only minor variations (0.10260.006 foci/cell). With increas-
ing age we observed a steady rise in the number of cH2AX-foci,
with significantly elevated foci levels in the age-group of ,50 years
(0.18460.015 foci/cell; p,0.001) and even higher foci levels in
the age-group of .50 years (0.24560.023 foci/cell; p=0.046).
Similar to their stem/progenitor counterpart, the more differen-
tiated CD342 cells obtained from cord blood revealed only low
cH2AX-foci levels with only minor variations (0.07460.006 foci/
cell). Moreover, cH2AX-foci analysis of CD342 cells revealed a
similar increase of unrepaired DSBs with increasing donor age,
with significantly elevated foci levels in the ,50 (0.14560.018
foci/cell; p#0.001) and .50 age-groups (0.24760.036 foci/cell;
p=0.004). These findings suggest that unrepaired DSBs accumu-
late continuously in hematopoietic stem/progenitor cells (CD34+)
and their more differentiated progeny (CD342) during physio-
logical aging.
Next, we examined the CD34+ and CD342 cells for their
abilities to respond to ionizing irradiation. The DSB repair
Figure 1. cH2AX-foci in hematopoietic stem and progenitor
cells. A: cH2AX-foci in CD34+ cells were enumerated at 0.5 h after
irradiation with doses from 10 mGy to 2000 mGy and plotted against
the irradiation dose. The induction of cH2AX-foci is clearly dependent
on the irradiation dose, with a linear correlation from 10 mGy to
1000 mGy. At foci levels of more than 15 foci per cell, the clustering of
foci impedes their clear discrimination, leading to an underestimation
of actual foci numbers (inset). B: Immunofluorescence double-staining
of cH2AX (green) combined with pATM, MDC1 or 53BP1 in CD34+ cells,
8 h after irradiation with 2 Gy. The clear co-localization with other DNA
repair factors confirms that cH2AX-foci can be used to analyze DSBs.
(Original magnification, 6600) C: Quantitative analysis of cH2AX-,
pATM-, MDC1- and 53BP1-foci in CD34+ cells at different time-points
after irradiation with 1 Gy. cH2AX-foci co-localize consistently with
other DNA repair factors. Error bars signify the SE of three different
experiments.
doi:10.1371/journal.pone.0017487.g001
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PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17487Figure 2. Accumulation of DSBs and declining DSB repair capacities with advancing age. The number of pre-existing cH2AX-foci (upper
panels), and radiation-induced cH2AX-foci at 8 hours (middle panel) and 24 hours (lower panels) after irradiation with 2 Gy was plotted against
donor age, depicted separately for CD34+ and CD342 cells. Linear regression analyses were performed (solid lines) and Spearman’s rank correlation
coefficients (rs) were calculated. For three different arbitrary groups (age: 0/,50/.50 years) mean cH2AX-foci levels are displayed in bar graphs. Error
bars represent the SE within the specific group. *Statistically significant difference to the next younger age group (p,0.05).
doi:10.1371/journal.pone.0017487.g002
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at defined time-points after irradiation with 2 Gy. At 0.5 h post-
irradiation comparable levels of cH2AX-foci were induced in
CD34+ and CD342 samples regardless of the donor age (data not
shown). In figure 2, the residual DSBs (cH2AX-foci per cell) were
plotted against the donor age, depicted separately for the repair-
times 8 h (middle panels) and 24 h post-irradiation (lower panels).
CD34+ and CD342 cells obtained from cord blood samples
generally revealed quite low levels of residual cH2AX-foci at 8 h
(CD34+: 4.27560.341 foci/cell; CD342: 4.23460.211 foci/cell)
and 24 h post-irradiation (CD34+: 1.72960.068 foci/cell;
CD342: 1.40660.081 foci/cell, compare insets), indicating fairly
efficient DSB repair capacities. In contrast, significantly higher foci
levels were registered at 8 h and particularly at 24 h post-
irradiation in the CD34+ and CD342 cells of the ,50 years age-
group (CD34+: 2.04760.068 foci/cell; p=0.007; CD342:
2.07260.063 foci/cell; p,0.001) and .50 years age-group
(CD34+: 2.47460.186 foci/cell; p=0.012; CD342: 2.7986
0.093 foci/cell; p,0.001, compare insets). Collectively, with
increasing age we observed rising levels of residual cH2AX-foci
after exposure to ionizing radiation, suggesting diminished DSB
repair capacities in older individuals.
To evaluate the relationship between endogenous accumulation
of unrepaired DSBs and individual DSB repair capacity, the pre-
existing cH2AX-foci were plotted against the residual foci (24 h
after irradiation) for every individual. As shown in Figure S1,
significant correlations between the level of naturally pre-existing
cH2AX-foci and residual foci after irradiation were noticeable in
CD34+, and even more pronounced in CD342 cells of different-
aged donors, suggesting that the individual DSB repair capacity
may determine the degree of DNA damage accumulation.
Previous studies have shown that the measurement of telomere
length can give valuable insight into the replicative history of cells,
indicating their biological age [23]. In the present study, we
correlated the telomere length and number of cH2AX-foci per cell
for CD34+ and CD342 cells. CD34+ and CD342 cells obtained
from umbilical cord blood revealed long telomeres (.9 kb) and
low cH2AX-foci levels for CD34+ (0.16460.031 foci/cell) and
CD342 cells (0.09760.017 foci/cell) (Fig. 3, upper panels).
Moreover, analyzing CD34+ and CD342 cells of healthy adults
we were able to confirm that telomere length shortens continu-
ously with age (Figure S2). This highly significant age-related
decline in telomere length was associated with increasing foci levels
in both CD34+ (8–9 kb: 0.18160.016 foci/cell; #8 kb:
0.25060.035 foci/cell; p=0.049) and CD342 cells (8–9 kb:
0.12560.018 foci/cell; #8 kb: 0.24360.032 foci/cell; p=0.002,
compare Fig. 3A insets). However, the Spearman’s correlation
coefficients (rs) describing the relationship between cH2AX-foci
per cell and donor age (Fig. 2, upper panels) or telomere length
(Fig. 3A), respectively, were clearly higher for the chronological
age.
Since telomere dysfunction in response to critical telomere
shortening may induce DNA damage responses, we assessed the
extent of co-localization between the cH2AX-foci and telomeres
by the combined immunofluorescence and telomere-fluorescence
in-situ hybridization (Fig. 3B; Figure S3). In CD34+ and CD342
cells obtained from cord blood and bone marrow of aged
individuals (.50 years) between 5–8% of the cH2AX-signals
coincided with telomere signals, whereas the frequencies of co-
localization were even slightly higher in cord blood derived HSCs
(Fig. 3C). Although these results indicate that some of the cH2AX-
foci are localized at or near telomeres, our findings do not support
the notion that progressive telomere shortening contributes to the
accumulation of cH2AX-foci in physiologically matured HSCs.
To explore the DNA damage accrual in different stem and
progenitor cell populations during healthy aging, we screened for
bone marrow samples of elderly individuals (.70 years) charac-
terized by a good health status, notably without any chronic
diseases. In subsequent experiments we analyzed the pre-existing
cH2AX-foci in CD34+CD382, CD34+CD38+ and CD342 cells
derived from bone marrow of these elderly donors and compared
their DNA damage accrual with the corresponding cell popula-
tions obtained from umbilical cord blood. In all cell fractions, we
observed significantly increased numbers of cH2AX-foci for these
elderly donors, with up to twice as high foci levels compared to the
cord blood derived subpopulations (Fig. 4, upper panel). Long-
lived CD34+CD382 cells revealed the highest level of cH2AX-
foci (.70 years: 0.22860.022 foci/cell; 0 years: 0.11260.014
foci/cell, p=0.005), maybe reflecting the continuous accumula-
tion of DNA damage during their extended lifespan. But also more
committed progenitor cells (CD34+CD382 and CD342) and
even peripheral blood mononuclear cells (PBMCs) revealed
elevated foci levels compared to the cord blood derived subtypes
(Fig. 4, upper panel). These findings indicate that these different
subtypes of hematopoietic stem and progenitor cells accumulate
persistent DNA lesions that may contain unrepairable DSBs.
In subsequent experiments, we quantified cH2AX-foci at 8 h
and 24 h after irradiation with 2 Gy, to find out whether
genotoxic insults such as ionizing radiation differently affect these
various subpopulations. Significantly, we observed a nearly
identical decline of cH2AX-foci levels in CD34+CD382,
CD34+CD38+ and CD342 cells after exposure to irradiation,
suggesting similar efficiencies of DSB processing in all analyzed
cell fractions (Fig. 4, middle and lower panel). Unexpectedly, the
DSB repair capacities of these different cell populations derived
from matured bone marrow and umbilical cord blood were
equally efficient, irrespective of their wide difference in donor age.
At first glance, these results appear to be contradictory to our
previous findings (compare Fig. 2), showing evidence for a decline
of DNA repair with age. However, these discrepancies can be
explained by our strict donor selection, suggesting that the
observed effectiveness of DNA repair in these elderly individuals
may be related to their excellent health status.
Discussion
Accumulation of DNA damage leading to adult stem cell
exhaustion has been proposed to be a principal mechanism of
aging. Here, we tested this hypothesis in healthy individuals by
examining unrepaired DNA damage in hematopoietic stem/
progenitor cells aged in their natural environment under physio-
logical conditions. Analyzing CD34+ and CD342 stem/progenitor
cellswe observed anincrease ofendogenous cH2AX-focilevels with
advancing donor age, associated with an age-related decline in
telomere length. Using combined immunofluorescence and telo-
mere fluorescence in-situ hybridization, we show that the age-
dependent increase of DNA damage involve predominantly non-
telomere-associated cH2AX-foci, arguing against the hypothesis
that telomere dysfunction in response to critical telomere shortening
plays a primary role in producing senescence- and age-associated
DNAdamage inhumans.The highestinter-individualvariationsfor
non-telomeric DNA damage were observed in middle-aged donors,
whereas the individual DSB repair capacity appears to determine
the extent of DNA damage accrual. However, analyzing different
stem/progenitor subpopulations obtained from healthy elderly
(.70 years), we observed an only modest increase in DNA damage
accrual, most pronounced inthe primitive CD34+CD382 enriched
subfraction, but sustained DNA repair efficiencies, suggesting that
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these findings we conclude that age-related non-telomeric DNA
damage accrual accompanies physiological stem cell aging in
humans. Moreover, aging may alter the functional capacity of
human stem cells to repair DSBs, thereby deteriorating an
important genome protection mechanism leading to exceeding
DNA damage accumulation. However, the great inter-individual
variations in middle-aged individuals suggest that additional cell-
intrinsic mechanisms and/or extrinsic factors contribute to the age-
associated DNA damage accumulation.
There is growing evidence that stem cell aging is not purely an
intrinsic process, but is also regulated by external stimuli within
specific microenvironments, the so called ‘‘stem cell niche’’. The
stem cell niche governs asymmetric cell division of two daughter
cells that may either self-renew to replenish the stem cell pool or to
differentiate to more committed cells. Furthermore, anchorage of
HSCs to specific niches in the bone marrow appears to support
and protect quiescent stem cells from damage and stress induced
exhaustion [24]. Recent results provide evidence, that the
supportive function of the niche is modified during the process
of aging, thereby affecting the extrinsic mechanisms of stem cell
control [25].
The integrity of the genome can be affected by a variety of
environmental and lifestyle factors which may contribute to the
impairments in organ maintenance and function during human
aging. Recent studies indicate that lifestyle factors (such as
nutrition, physical exercise, tobacco smoking, alcohol consump-
tion) have an age-independent influence on the accumulation of
DNA damage and telomere dysfunction in human blood [26].
Moreover, there are emerging reports that lifestyle interventions
can reduce the levels of DNA damage and telomere shortening in-
vivo [27–29].
Figure 3. Accumulation of DSBs and progressive telomere-shortening. A: The number of pre-existing cH2AX-foci per cell was plotted
against telomere length depicted separately for CD34+ and CD342 cells. Linear regression analyses were performed (solid lines) and Spearman’s rank
correlation coefficients (rs) were calculated. For three different arbitrary groups (telomere length: ,8/8–9/.9 kb) mean cH2AX-foci levels are
displayed in bar graphs. Error bars represent the SE within the specific group. *Statistically significant difference to the next younger age group or
next group with shorter telomere (p,0.05). B: Co-localization between cH2AX- and telomere-signals. Co-localization of endogenous cH2AX-foci (red)
with telomere-specific DNA (green FISH signal). DAPI staining (blue) indicates DNA. (Original magnification, 6600) C: Quantitative analysis of the
extent of co-localization between cH2AX- and telomere-signals. In CD34+ and CD342 cells obtained from cord blood and bone marrow of aged
individuals (.50 years), respectively, approximately 200 cH2AX-foci were screened per data point in independent experiments. Error bars signify the
SE of five different experiments.
doi:10.1371/journal.pone.0017487.g003
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lation of DSBs and decline in DSB repair functions in human
HSCs aged in their physiological microenvironment. Thus, DNA
damage accrual is not a response to artificial cell cultures
conditions (as previously discussed in aging fibroblasts), but may
be part of both intrinsic and extrinsic mechanisms governing the
physiological aging process in human stem cells. HSCs obtained
from umbilical cord blood exhibited low levels of endogenous
DNA damage and highly efficient DNA repair capacities with only
minor inter-individual variations (Fig. 2). In contrast, HSCs of
middle-aged (,50 years) and even more pronounced of aged
donors (.50 years) revealed clearly higher amounts of unrepaired
DNA damage and less efficient repair capacities, with broader
variations in both DSB accumulation and repair capacities (Fig. 2).
These results suggest that inter-individual differences in DSB
accumulation and repair become more apparent with increasing
age, maybe reflecting different lifestyle exposures (such as smoking
or obesity) that may contribute to aging. However, analyzing
different stem and progenitor subpopulations obtained from
healthy elderly (.70 years), we observed only modest increase in
DNA damage accrual and sustained DNA repair efficiencies,
suggesting that healthy lifestyle may slow down the natural aging
process. In actual fact, our exploration of healthy elderly implies a
strict selection as only individuals reaching an advanced age in
good health and without any chronic diseases were included in this
study. Thus, analyzing healthy elderly the whole spectrum of inter-
individual differences in age-dependent DNA damage accumula-
tion and repair is certainly not covered in this clinical study.
In most mature cells, eroding telomeres act as an internal clock
that limits the number of divisions that a cell can perform [23]. In
contrast, stem cells often express telomerase which can elongate
telomeres and extend their replicative potential [15]. In line with
former studies, we could previously show that the CD34+ cell
populations from healthy donors uniformly express only baseline
telomerase activity, not sufficient to maintain telomere length
during aging [16,22]. In the present study we could confirm an
age-related shortening of telomeres in both CD34+ and CD342
cells (Figure S1), associated with increasing levels of unrepaired
DNA damage (Figure 3, upper panel). Oxidative stress has been
shown to be a major causal factor for telomeric DNA damage
contributing to telomere attrition [30]. Thus, it appears likely that
telomere damage leading to telomere-shortening is functionally
interrelated with endogenous DSBs, probably both induced by
oxidative stress [31]. However, plotting the endogenous cH2AX-
foci against the telomere length (instead of chronological donor
age) revealed lower correlations coefficients in CD34+ and
CD342 cells (Fig. 3A), indicating that the age-related increase
of DNA damage may derive from telomere-independent mecha-
nisms. Moreover, we assessed the extent of co-localization between
cH2AX-foci and telomeres in CD34+ and CD342 cells obtained
from cord blood and bone marrow of aged donors. Irrespective of
the donor age only a low percentage of the cH2AX-signals
coincided with telomere signals, strongly supporting a non-
telomeric origin for the majority of cH2AX-foci (Fig. 3B, C;
Figure S3).
In our study we observed a significant correlation between the
amount of unrepaired DSBs and the DSB repair capacity (Fig. 2,
Figure S1), suggesting that the DSB repair itself may change with
age and that the age-associated increase of unrepaired DSBs may
reflect the reduced efficiency of NHEJ, leading to slower
processing of DSBs. In addition, NHEJ cannot accurately
reconstitute sequence information lost at DSBs, and thus may
result in mutational changes at the site of repair [32]. Previous
work finds evidence that the efficiency and fidelity of NHEJ
declines during cellular senescence in human fibroblasts, and
therefore DSB resolution becomes clearly more error-prone with
age [33]. Based on our data we suggest that this age- and probably
lifestyle-related decline in DSB repair may lead to a self-amplifying
cycle with delayed kinetics in DSB processing reflecting a
decreased efficiency and fidelity of repair processes leading to
the accumulation of mutations. Accrual of genomic damage in
turn may cause a gradual decline of the functional capacity to
repair DNA damage, thereby contributing to genomic instability
and, ultimately, to stem cell exhaustion.
Many proteins involved in the DNA damage response aggregate
as microscopically visible foci at sites of DSBs after exposure to
Figure 4. Accumulation of DSBs in the different stem/
progenitor populations during healthy aging. The number of
pre-existing cH2AX-foci (upper panel), and radiation-induced cH2AX-
foci at 8 hours (middle panel) and 24 hours (lower panel) after
irradiation with 2 Gy was counted in CD34+CD382, CD34+CD38+,
CD342 and PBMC cells derived from cord blood (0 years) and bone
marrow of healthy elderly (.70 years). Error bars represent the SE
within the specific group. *Statistically significant difference to the
corresponding cord-blood derived stem/progenitor population
(p,0.05).
doi:10.1371/journal.pone.0017487.g004
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cH2AX-foci may indicate the presence of unrepaired or
misrepaired DSBs. However, our understanding of the biological
relevance of residual DNA repair foci still remains limited. Recent
experimental findings suggest that persisting cH2AX-foci may
reflect chromatin alterations after DNA rejoining rather than
unrepaired DSBs [34]. DSB repair is a highly coordinated process
that requires the unraveling of the compacted chromatin structure
to facilitate repair machinery access and then restoration of the
original undamaged chromatin state. Incomplete or incorrect
restoration of chromatin structure can leave a DSB-induced
epigenetic memory of damage with potentially pathological
repercussions. Considering the critical importance of chromatin
organization to correct gene expression control, proper restoration
of epigenetic patterns following DSB damage would be crucial to
avoiding perturbation of transcriptional programs, involving the
aberrant activation or silencing of genes. Moreover, preservation
of transcriptional states essential to cell identity and function
requires the correct, high-fidelity propagation of the underlying
pattern of epigenetic marks from mother to daughter cell. It is
therefore conceivable that our finding of similar endogenous
cH2AX-foci levels in different stem and progenitor cells derived
from the same individual may reflect the faithfully reproduced
epigenetic information in the event of damage, resulting in
chromatin alterations that are transmissible over multiple cell
generations. Another important point in this context is the varying
chromatin architecture in the course of lineage-specific differen-
tiation. Lineage-restricted cells generally have more condensed
chromatin architecture than pluripotent stem cells which employ
unique histone modifications to regulate the balance between
pluripotency and differentiation [35]. Recent studies have shown
that pluripotent mouse embryonic stem cells exhibit excessive
numbers of cH2AX-foci in the absence of measurable DSBs,
which appear to be associated with global chromatin decondensa-
tion rather than pre-existing DNA damage [36]. However,
analyzing the formation and removal of cH2AX-foci in the
different stem and progenitor cells (CD34+CD382,
CD34+CD38+ and CD342 subpopulations) we observed no
differences in the induction and repair kinetics, suggesting that
potential differences in their chromatin organization seem to have
no impact on sensing and processing of radiation-induced DNA
damage.
Advancing age is accompanied by a number of pathophysio-
logical changes in the hematopoietic system, whose etiology
suggests loss of homeostatic control and possible stem/progenitor
cell involvement. The most clinically significant of these changes
are the decreased competence of the adaptive immune system
[37,38], and the increased incidence of leukemia and lymphoma
[39]. Due to the low number of available cells in our clinical study,
we could not examine whether or not aging affects the number
and/or function of human HSCs. However, clinical data indicate
that advanced donor age is a strong negative prognostic marker for
survival in allogenic bone marrow transplantations, which might
indicate impaired function of HSCs from aged donors [40].
Conclusions
Our study provides compelling evidence that the accumulation
of DNA damage and the reduced ability to repair DNA damage
plays an important role in the physiological aging of humans.
Given the close association between aging and cancer develop-
ment, the relevance of these observations has wider implications.
Only tissue stem cells possess the proliferative capacity and lifespan
necessary to accumulate genetic damage, and are therefore
considered to be the principal target for transforming mutations
leading to cancer. Decreasing efficiencies in DSB repair may
contribute to genomic instability in tissue stem cells and successive
mutagenic events may result in both gradual decline of stem cell
functions and tumor formation. Increased incidence of cancer with
age is the best-known evidence of age-related genomic instability.
A better understanding of the underlying mechanisms governing
the aging process could ultimately lead to the development of
molecular strategies aiming to treat age-related degenerative and
malignant diseases.
Supporting Information
Figure S1 The individual DSB repair capacity deter-
mines the degree of endogenous DNA damage accumu-
lation. Pre-existing cH2AX-foci were plotted against the residual
foci (24 h after irradiation with 2 Gy) for every individual,
depicted separately for CD34+ and CD342 cells. Linear
regression analyses were performed (solid lines) and Spearman’s
rank correlation coefficients (rs) were calculated.
(TIF)
Figure S2 Age-related telomere shortening. Telomere
lengths were plotted against the donor age, depicted separately
for CD34+ and CD342 cells. Linear regression analyses were
performed (solid lines) and Spearman’s rank correlation coeffi-
cients were calculated.
(TIF)
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